Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Philippidis

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Human Gene Therapy|August 17, 2023
BioMarin's ROCTAVIAN Wins Food and Drug Administration Approval As First Gene Therapy for Severe Hemophilia AAlex Philippidis
Human Gene Therapy|April 16, 2024
Orchard Therapeutics Gains First U.S. Approval for a Metachromatic Leukodystrophy Gene TherapyAlex Philippidis
Human Gene Therapy|March 27, 2025
Beam Results Show First Genetic Correction of Disease-Causing MutationAlex Philippidis
Human Gene Therapy|June 24, 2025
10-Month-Old Boy Makes History as World's First Patient Treated with Personalized CRISPR TherapyAlex Philippidis
Human Gene Therapy. Clinical Development|December 22, 2018
Gene Therapy BriefsAlex Philippidis
Human Gene Therapy|January 19, 2023
Fyodor Urnov Articulates New Model for Developing, Financing TherapiesAlex Philippidis
Human Gene Therapy|June 11, 2025
FDA Names Prasad CBER Director, Sparking Gene Therapy Review ConcernsAlex Philippidis
Human Gene Therapy|July 20, 2021
<b>CRISPR-Cas9 Gene-Edited Therapy Shows Sustained Treatment Response</b>Alex Philippidis
Human Gene Therapy|May 7, 2025
Marks' Resignation Sparks Concerns on FDA Regulation of Gene TherapiesAlex Philippidis
Human Gene Therapy|December 18, 2023
Activist Investor Reported to Take $1 Billion Stake in BioMarinAlex Philippidis
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Human Gene Therapy|August 17, 2023
BioMarin's ROCTAVIAN Wins Food and Drug Administration Approval As First Gene Therapy for Severe Hemophilia AAlex Philippidis
Human Gene Therapy|April 16, 2024
Orchard Therapeutics Gains First U.S. Approval for a Metachromatic Leukodystrophy Gene TherapyAlex Philippidis
Human Gene Therapy|March 27, 2025
Beam Results Show First Genetic Correction of Disease-Causing MutationAlex Philippidis
Human Gene Therapy|June 24, 2025
10-Month-Old Boy Makes History as World's First Patient Treated with Personalized CRISPR TherapyAlex Philippidis
Human Gene Therapy. Clinical Development|December 22, 2018
Gene Therapy BriefsAlex Philippidis
Human Gene Therapy|January 19, 2023
Fyodor Urnov Articulates New Model for Developing, Financing TherapiesAlex Philippidis
Human Gene Therapy|June 11, 2025
FDA Names Prasad CBER Director, Sparking Gene Therapy Review ConcernsAlex Philippidis
Human Gene Therapy|July 20, 2021
<b>CRISPR-Cas9 Gene-Edited Therapy Shows Sustained Treatment Response</b>Alex Philippidis
Human Gene Therapy|May 7, 2025
Marks' Resignation Sparks Concerns on FDA Regulation of Gene TherapiesAlex Philippidis
Human Gene Therapy|December 18, 2023
Activist Investor Reported to Take $1 Billion Stake in BioMarinAlex Philippidis
Pageof 11